Next Article in Journal
Risk Factors for the Acquisition of Enterococcus faecium Infection and Mortality in Patients with Enterococcal Bacteremia: A 5-Year Retrospective Analysis in a Tertiary Care University Hospital
Previous Article in Journal
Real-World Use of Generic Meropenem: Results of an Observational Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Are We Making the Most of Community Pharmacies? Implementation of Antimicrobial Stewardship Measures in Community Pharmacies: A Narrative Review

1
Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia
2
The Split-Dalmatia County Pharmacy, Dugopoljska 3, 21 204 Dugopolje, Croatia
3
Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia
*
Author to whom correspondence should be addressed.
Antibiotics 2021, 10(1), 63; https://doi.org/10.3390/antibiotics10010063
Submission received: 28 December 2020 / Revised: 5 January 2021 / Accepted: 7 January 2021 / Published: 11 January 2021
(This article belongs to the Section Antibiotics Use and Antimicrobial Stewardship)

Abstract

:
Community pharmacists recognize the need to implement antimicrobial stewardship activities in community pharmacies. They are in a unique position to provide triage for common primary care indications and to lower the burden of patients at general practitioners’ offices. However, research shows that, in some areas, dispensing of antimicrobials without valid prescription is still highly prevalent. Regardless of training, every community pharmacist can give his contribution to antimicrobial stewardship. One of the basic elements should be antimicrobial dispensing according to regulations, either prescription only, or according to guidelines where pharmacists have prescribing authority. Patient consultation supported with educational materials, such as leaflets, may reduce patients’ expectations to receive antibiotics for self-limiting infections and reduce pressure on general practitioners to prescribe antibiotics on patients’ demand. Treatment optimization may be achieved in collaboration with the prescribing general practitioners or by providing feedback. At last, pharmacists provided with additional training may be encouraged to provide consultation services to long-term care facilities, to introduce point-of-care testing for infectious diseases in their pharmacies or prescribe antimicrobials for uncomplicated infections. These services are welcomed by patients and communities. Expanding pharmacy services and pharmacists’ prescribing autonomy have shown a positive impact by reducing antibiotics consumption, thus ensuring better compliance with treatment guidelines.

1. Introduction

Antimicrobial resistance is among the leading global health threats to the modern world. Among the identified contributors to the emerging resistance is inappropriate antimicrobial consumption, which may be facilitated through increased antimicrobial availability in a community [1,2]. Preservation of public health requires every healthcare worker to be included in efforts to reduce the emergence of antimicrobial resistance [3]. With greater antibiotics consumption at outpatient settings, with estimates that around half of the antibiotics prescribed in the outpatient setting are unnecessary or inappropriate, there is an evident need for utilizing antimicrobial stewardship programs in outpatient settings [4]. According to Dyar et al., antimicrobial stewardship is “a coherent set of actions designed to use antimicrobials responsibly”. To combat rising antimicrobial resistance, several antimicrobial stewardship strategies have been proposed and implemented at the hospital and community level [3]. These include, but are not limited to, developing local treatment guidelines according to local pathogen-susceptibility data, establishing antimicrobial stewardship teams in tertiary care centers, preauthorization of prescriptions and post prescription audit and review, education and practical training, monitoring antimicrobial use and disease epidemiology [5,6].
Community pharmacists serve as gatekeepers to antimicrobial use. However, there are different regulations around the world; e.g., in some countries antimicrobials are prescription-only, in some there are topical antimicrobials available over the counter and in others most antimicrobials are sold without prescription. In Tanzania, dispensing of antibiotics without a prescription is common, although they are classified as prescription-only drugs. According to results of a study by Horumpende et al. antibiotics can easily be obtained without a prescription in up to 92% of pharmacies [7,8]. Even if designated as prescription-only, some pharmacists may dispense antimicrobials without a valid prescription and this issue seems to be more prominent in low- and middle-income countries, but is also widely present in some high-income countries [9,10,11,12,13,14,15,16,17,18,19]. A meta-analysis by Auta et al. on 38 studies in 24 countries estimated the overall proportion of antibiotics dispensed without a valid prescription at 62%. Only one of the included countries did not classify antibiotics as prescription-only drugs (Thailand). The proportion of dispensing non-prescribed antibiotics ranged from 8.2% for scenarios of symptoms of STDs and gastroenteritis in Zimbabwe to up to 97.6% in Saudi Arabia for patient requests for co-amoxiclav or cefaclor, indicating that antibiotics are frequently supplied without prescription, even in areas where this practice is illegal [18].
Ways in which to contribute to antimicrobial stewardship should be brought to the attention of every healthcare professional and stakeholder [3]. Publications describing community pharmacists’ efforts to contribute to reducing antibiotics consumption and describing community pharmacists’ participation in antimicrobial stewardship programs are included in this comprehensive review.

2. Antimicrobial Stewardship in Community Pharmacy

2.1. Awareness of and Barriers to Implementing Antimicrobial Stewardship Programs at the Primary Care Pharmacy Level

Pharmacists believe antimicrobial stewardship programs should be incorporated into community pharmacies, but that it requires them to receive more training and that any additional efforts should be adequately reimbursed [20,21,22,23,24]. Most pharmacists (more than 70%) believe that they play a key role in helping to control the use of antibiotics and consider educational campaigns as one of the most important strategies that can be adopted to combat antimicrobial resistance [25,26,27,28].
Pharmacists can discourage unnecessary visits to physicians and provide self-care advice when possible [29]. In addition to maintaining the drug supply in a community, they make efforts to prevent and reduce infections in the community, educate patients, communicate with prescribers, evaluate the appropriateness of the prescribed antibiotic and have a good understanding of the necessity of returning unused drugs for antimicrobial stewardship [30,31]. Some recent studies showed that there are still pharmacists that are unaware of antimicrobial stewardship programs, some have misconceptions about the development of antimicrobial resistance and some even report dispensing antimicrobials without a valid prescription [8,21,32,33].
A recent study investigating behaviors related to antimicrobial stewardship for respiratory tract infections in primary care found that 5 of 32 were community pharmacy behaviors, mostly patient education [34]. A study by Revolinski et al. showed varied antimicrobial stewardship practices in community pharmacies, with patient education and allergy assessment being among the most prevalent [35]. Even though pharmacists perceive the developed tools and guides as useful sources for patient education, they are poorly utilized among pharmacies due to poor dissemination [21,22,29]. There are other barriers in implementing different antimicrobial stewardship programs at the pharmacy level, including adequate funding, no prescribing options, no access to medical records and difficulties in contacting the consumers’ general practitioner [22,27,36].
Underutilization of pharmacists is possibly best described in a study by Charany et al., including 505 healthcare professionals from 53 countries, who revealed that the number of pharmacists who had postgraduate training in antibiotic management is less than for doctors and nurses (35% vs. 58% vs. 43%, respectively), but frequently reviewed prescriptions (90%) and developed guidelines more frequently then colleague doctors and nurses (57% vs. 47% vs. 18%); this indicates that pharmacists impose themselves as medication experts regardless of additional training [37].

2.2. Common Primary Care Indications

Community pharmacists remain the most accessible healthcare workers, and with most antimicrobials consumed at the primary care level, pharmacists are in a unique position to contribute to the management of antimicrobial resistance. With the estimated high accessibility of over-the-counter antimicrobials [18], pharmacists need to be reminded to rationally and conscientiously dispense antimicrobials. Opportunities for implementing antimicrobial stewardship at primary care community pharmacy level are summarized in Figure 1.
Patient education and consultation on adequate self-medication when antibiotics are not needed may be the key element to handle patients who demand antimicrobials [38]. Even more, patient education should include stressing the importance of adherence to antimicrobial treatment and the importance of adequately disposing of unused drugs [31]. Some authors are problematizing the accordance of registered and available drug-pack sizes with treatment guidelines, further stressing the importance of patient adherence to the treatment. Even with perfect patient adherence to the treatment, there still might be leftover units of antibiotics that raise the risk of improper treatment in the future if these are left stocked at home [39,40,41]. Furthermore, community pharmacists play a key role in addressing patient concerns regarding possible adverse drug reactions, optimizing patient outcomes and referring patients to general practitioners when appropriate [42,43]. Other contributions of community pharmacists may include treatment optimization regarding dose, duration of the treatment or formulation where there is a well-established collaboration with the prescribers, alongside providing feedback to the prescribing physician and educating other healthcare team members [44]. Where possible, usually following additional training or in collaboration with a physician, community pharmacists may utilize immunization services, rapid infectious disease testing or even prescribe antimicrobials for common uncomplicated infections.

2.2.1. Upper Respiratory Tract Infections

According to a study by Hersh et al., investigating the appropriateness of prescribed antibiotics for otitis media, sinusitis and pharyngitis (indications accounting for one third of prescribed antibiotics in outpatient setting), only 52% were found to be first-line agents [45]. Prescribers in outpatient settings are influenced by clinical uncertainty and time constrains and are often pressured by patients to prescribe antibiotics [46]. These observations highlight the need for outpatient antimicrobial stewardship [47].
Community pharmacists are recognized as antimicrobial stewards for upper respiratory tract infections, as they have the opportunity to communicate with both patients and prescribers and have specialist knowledge of drugs [47,48]. They can especially influence inappropriate antibiotics consumption, and among the possible targets for reducing inappropriate antibiotic consumption is a sore throat, as in most adult patients (around 90%) it is of viral origin [49].
Among the factors influencing the prescribers’ decision to provide antibiotics is diagnostic uncertainty [46]. There have been efforts to overcome this in a community pharmacy setting by providing “triage” and point-of-care testing to sore-throat patients and dispensing treatment in a community pharmacy where possible or referring to a physician when appropriate. The Centor score and modified Centor score are widely used to assess the etiology of pharyngitis using clinical presentations [50]. A study by Saengcharoen et al., conducted among more than 700 pharmacists in Thailand, evaluated how well pharmacists are diagnosing streptococcal pharyngitis and dispensing antibiotics. The results showed pharmacists’ knowledge on pharyngitis was negatively associated with dispensing antibiotics and pharmacists’ belief that patient satisfaction is achieved with receipt of antibiotics was associated with greater antibiotic dispensing. Moreover, pharmacists who were well familiar with the Centor criteria were taking more patient symptoms into account and were less likely to dispense antibiotics [51].
Such tools have been coupled with other scoring systems and further been expanded with point-of-care testing for infectious diseases [52,53]. Sensitivity and specificity estimates for these tests are promising, but cost-effectiveness of adopting them in a primary care setting is still debatable [54]. A group of researchers from France introduced point-of-care testing for detection of group A streptococci (GAS) across community pharmacies. Pharmacists participated in a 2 h training session on respiratory tract infection and training on rapid antigen-test use. The protocol consisted of a GAS pharyngitis risk assessment according to the modified Centor score and rapid antigen test for patients with a score of 2 or above. Patients were routinely instructed to consult a general practitioner if symptoms worsen or persist after 72 h. Based on the Centor score, GAS pharyngitis was suspected in 65.7% of patients, and 91.6% were further tested in pharmacies. These resulted in only 8.3% positive rapid antigen tests, accounting for 5% of the total included population. Patients who tested positive were instructed to consult a general practitioner since pharmacists in France do not have prescribing authority for antibiotics. Furthermore, all patients were provided with educational leaflets. Based on the follow-up on 38.5% of patients, all or almost all patients (99%) were satisfied with the rapid antigen test and positively judged the educational leaflets. Most pharmacists estimated the average time to conduct the entire protocol at 6 to 15 min, and 91.6% considered this duration appropriate and convenient. All the included pharmacists considered the rapid antigen test easy to use with 75.7% not having any difficulty performing the pharyngeal swab [52]. Upon introduction of a sore throat test and treating service across community pharmacies in Wales, pharmacists were trained on throat examination, scoring tools and sampling with a throat swab. A rapid antigen test was offered to patients scoring FeverPAIN > 3 or Centor > 2. After evaluation with the Centor or FeverPAIN scale, 72% of the patients were eligible for the rapid antigen diagnostics test, 28.2% tested positive and 27.4% received antibiotic treatment. For the purpose of the study, antibiotics could be supplied directly by the pharmacist under a Patient Group Direction. Follow-up was conducted on 51.9% of patients, of which 91.6% reported feeling better after using the service [55].
Introduction of a collaborative physician and community pharmacist GAS pharyngitis management program across community pharmacies proved that with physician consultation, pharmacists were able to identify patients likely to have GAS pharyngitis and provide timely treatments. Out of 86.4% patients eligible for testing, 17.6% had a positive test result. Follow-up (including 61.9% of patients) revealed that 76.3% of patients felt better, but 5.9% felt worse and 7.7% chose to seek additional care [56]. In another study offering GAS testing in community pharmacies, 48.8% of patients with a Centor score of 1 or 2 (not showing signs of a bacterial infection) would have consulted a general practitioner if the pharmacy service had not been available. Of those, 38.1% received a throat test, of which 59.5% tested negative. In total, antibiotics were supplied to 9.8% of patients directly by the pharmacist under the authority of a Patient Group Direction. The pharmacists’ completed training includes clinical examination, warning signs requiring referral and swabbing techniques. General practitioners’ offices located near the participating pharmacies were aware of the service and were encouraged to refer patients to the pharmacy. Considering the proportion of patients referred to general practitioners (n = 56) and patients who chose the pharmacy service instead of general practitioner consult (n = 97), possible savings were identified [57].
In another study, to overcome critics of the test accuracy, pharmacist offered influenza and GAS point-of-care tests based on rapid polymerase chain reaction according to a prespecified protocol using the Centor score scale; they performed the test, offered treatment with antibiotics, antivirals or over-the-counter drugs and followed-up with patients after 48 h. Among the patients tested for GAS, three-fourths reported feeling better, 13% were the same and just 1 patient felt worse. Among the patients tested for influenza, upon follow-up, two-thirds of the patients contacted reported feeling better, 17% reported feeling the same, and only 3.5% felt worse. Around 20% of patients were tested for both GAS and influenza, resulting in 4.7% positive GAS tests and 39.5% positive influenza tests. More than 25% of patients were seen on weekends or after 4 p.m. on weekdays, indicating such services offer greater accessibility to patients not only because of the wide community pharmacy distribution, but also because of convenient and longer working hours [58].
Research shows that antimicrobials are prescribed in 60% of cases of sore throat, hence there is space for reducing antibiotics prescribing, especially in this indication [59,60]. Other experience with point-of-care testing in pharmacy settings has shown that it may lead to reduced total antibiotics consumption, for example, drugs for antimalarial use [61].
Pharmacists gave positive feedback as to the feasibility of rapid antigen tests in pharmacies and considered the duration of the test acceptable, which is in direct contrast to general practitioners who identify a lack of time as the greatest barrier for rapid antigen test implementation in daily practice [52,62,63]. According to a published study, the average additional time of a point-of-care community pharmacy test for GAS was 25.3 ± 4.8 min, with an average pharmacist participation time of 12.7 ± 3.0 min. Total encounter time accounted for time from patient arrival, screening, patient completion of paperwork/review of symptoms, pharmacist consultation, physical assessment, performing the point-of-care test and waiting for the results and patient consultation on the treatment plan. Time to dispense a prescription, where appropriate, and time for recommendation of over-the-counter products for symptomatic treatment were not considered for total time, as both are part of the existing pharmacy workflow [64]. As described studies implicate, implementing sore throat test services in community pharmacies may reduce visits to a doctor’s office for uncomplicated sore throats [65]. Moreover, point-of-care testing promotes the choice of appropriate treatment and research shows that patients would be willing to use the service again even if they had to pay for such services [44,53,58].
In a study by Ashiru-Oredope et al., pharmacists underwent antimicrobial stewardship training and were encouraged to provide the Treat Antibiotics Responsibly, Guidance, Education, Tools: treating your infection—respiratory tract infection (TARGET TYI-RTI) leaflet to share with consumers who are seeking advice about self-limiting respiratory infections. The leaflet is both a resource and tool for clinicians to use during consultations and take-home information for patients, including information about the usual duration of common self-limiting respiratory infections, how to self-care and when to contact a healthcare professional. The study showed that providing community pharmacists with tools to enhance and optimize their interaction with patients was associated with a greater provision of self-care advice and less referral to the general practitioners for middle ear infections, sinusitis and coughs, especially for patients who received written information and were offered non-prescription drugs [25]. A study by van der Velden et al. further supports patient education in the treatment of sore throat, as the way healthcare providers communicate with patients can impact the treatment outcomes and patient satisfaction, stressing that patients seeking advice should be provided with written information about the management of sore throat [66].
In areas with a delayed antibiotic prescribing approach, pharmacists may facilitate its implementation by refusing to fill a delayed prescription (65%) or by providing additional advice to patients seeking antibiotics immediately after visiting general practitioners (29%) [67].
Actions that influence behavior in a way to enable responsible antimicrobial use or to limit inappropriate or unnecessary use of antimicrobials are key elements of antimicrobial stewardship [3]. Considering reports of many unnecessary or inappropriate antibiotics prescribed for sore throat, upper respiratory tract infections are a great opportunity for treatment optimization [68]. With most sore throat cases being of viral origin, good management of upper respiratory tract infections relies on patient education and on self-care and rapid diagnostics, both of which may be provided in a community pharmacy setting [49].

2.2.2. Uncomplicated Urinary Tract Infections

Research shows that 25–30% of patients experiencing symptoms of urinary tract infection refer to a community pharmacy prior to going to a general practitioner. England uses the Treat Antibiotics Responsibly, Guidance, Education, Tools: urinary tract infection (TARGET UTI) leaflets designed to increase consumers’ confidence in self-care and to facilitate communication between healthcare professionals and consumers. Most patients were comfortable discussing symptoms if it was done privately and not over the counter. Pharmacists included in the study concluded that they could act as a first-line triage for consumers with urinary tract infections. Furthermore, the study identified the benefits of providing such advice in a community pharmacy setting rather than general practitioner’s office—no appointment needed, long working hours and pharmacists are educated and confident in providing advice. Pharmacist recognize that routinely providing patients with self-care advice for common uncomplicated infections is one of the key elements of their role, with the well-being and health of their patients being their motivation, rather than financial incentives. Moreover, ensuring patient compliance is the key responsibility for community pharmacists [36]. Time-saving resources are beneficial to assist pharmacists in providing self-care advice and treatment advice to patients. Providing patient education can not only prevent unnecessary visits to the general practitioner’s office and unnecessary antibiotics treatment, but can also prevent future antibiotics use, contributing to tackling antimicrobial resistance on multiple fronts [29].
Introducing pharmacist-led stewardship programs at a community-based, family medicine residency clinic, has proven to significantly contribute to the prescribing of appropriate antibiotics, doses and duration of treatment for uncomplicated cystitis and pyelonephritis [69].
Reclassification of trimethoprim in New Zealand gave pharmacists authority to treat some urinary tract infections following a specified training. Additionally, a screening tool is available to ensure the correct dispensing of the treatment. This practice did not appear to influence medical prescribing of antibiotics or to increase the overall use of antibiotics. Although only a small proportion of patients were eligible for pharmacist-prescribed trimethoprim, such practices may contribute to easing the burden and pressure to general practitioners’ offices and could also have a positive effect on reducing demands for antibiotic prescriptions from general practitioners [70]. In a study by Beahm et al., pharmacists performed patient assessments for symptoms of urinary tract infections, prescribed or modified treatment, provided education and referred to physicians when applicable. Follow-up was conducted after two weeks to evaluate adherence to treatment, adverse reactions and to confirm resolution of symptoms. Good adherence was established in more than 95% of patients and an initial cure was achieved in 94.5% of patients [71]. Research has confirmed the high confidence among pharmacists to provide treatment for uncomplicated urinary tract infections [72]. Such interventions showed significantly shorter time from decision to seek care from a pharmacist (1.7 ± 2.4 days) compared to time from decision to seek care from a physician (2.8 ± 3.8 days) [71]. This data is amplified with the great satisfaction of patients with pharmacists’ accessibility and a reduction in visiting a general practitioner’s office [71,73]. Furthermore, in patients who were prescribed drugs by a physician first, pharmacists modified 40.4% of prescriptions [71].
According to a study from Canada, management of uncomplicated urinary tract infections by pharmacist seems to also be of lower cost when compared to general practitioner and emergency physician-initiated management [74]. Additionally, such practices have shown that patients would be less likely to seek a general practitioner consultation if antibiotics became available through community pharmacies due to convenience [75].

2.3. Pharmacist as a Member of a Multidisciplinary Team

Pharmacists greatly contribute to the development and implementation of stewardship programs, they educate other health care members, and track, report and assess the effectiveness of stewardship strategies. Including a pharmacist is the starting point of antimicrobial stewardship program team building and can promote consensus in multidisciplinary healthcare teams regarding prescription rights [4,76,77]. In transition from inpatient to outpatient care, pharmacists may contribute to limiting overall inappropriate antimicrobial prescribing, optimize antibiotic selection, dose or reduce treatment duration [44].
Pharmacists that received additional training in infectious diseases and antimicrobial stewardship programs may assist in educating other members of the healthcare team and patients on elements of antimicrobial stewardship. Pharmacists can conduct antimicrobial regimen reviews and offer advice on doses and frequency optimization, as well as suggest discontinuation or change of treatment [35,44].
A study by Thornley et al., conducted among community pharmacists during pharmacist advice visits in long-term care facilities across England, found that pharmacists intervened for 9.5% of prescribed antibiotics. These interventions included clinical/allergy check (53.4%), issues with timing and continuation (32.2%), referral to a general practitioner (6.8%), error identified, sample recommended for testing and formulation change recommended (2.5% each) [78]. Such facilities have high rates of antibiotic consumption, offering community pharmacists a great opportunity to introduce infection prevention measures and ensuring the appropriate and effective use of antibiotics upon dispensing them [79].
In a study conducted in Japan in a retirement home with nursing care, pharmacists received 5-day training (workshops supervised by an infectious-disease specialist) on on-site Gram staining and assisted physicians on diagnosis and treatment selection. Sputum, urine and exudate samples were tested for pneumonia, urinary tract infections or cellulitis. If sampling could not be performed, pharmacist would advise on prescribing antibiotics that cover all likely pathogens. Researchers observed less prescribed antimicrobials per 100 residents with the total number of prescribed antimicrobials decreasing over 40% and continuing to drop over the course of the years. An increase in first-generation cephalosporin prescriptions was observed, alongside a decrease in third-generation cephalosporin prescriptions, indicating a wide- to narrow-spectrum switch post-intervention [80].

2.4. Other Considerations

2.4.1. Penicillin Allergy

Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems and monocyclic beta-lactams) make up to 65% of all injectable antibiotics in the United States [81]. Penicillins are among the most commonly dispensed antibiotics in primary care [82]. Therefore, it should come as no surprise that these antibiotics are widely present in treatment guidelines for common uncomplicated infections, especially respiratory tract infections of bacterial etiology [81]. Unfortunately, a reported penicillin allergy in patients may limit available treatment options for most common infections seen in primary care, such as such reactions may extend to other beta-lactams and discourage prescribers to administer them, pressuring second- and third-line antimicrobials for treatment. Other consequences of such a label include increased mortality risk during cancer and infection treatment, delay of initiation of appropriate antimicrobial therapy, increase in treatment failures or surgical infections, associated increase in multidrug-resistant infections and longer lengths of stay, all together leading to higher healthcare costs [83]. Penicillin allergy may be confirmed through evaluating the type of allergy/adverse drug reaction, interview and penicillin skin testing. Only a small proportion of patients with reported penicillin allergy have a history of a high-risk reaction. Numerous studies suggest that the proportion of negative allergy penicillin skin tests in patients with documented penicillin allergies ranges from 79% to 100% [83,84,85]. Such services are usually pharmacist-directed under a collaborative practice agreement [86,87]. Furthermore, these services can be implemented in an outpatient setting with pharmacists doing an in-depth interview and referring eligible patients for further testing or suggesting immediate allergy de-labelling based on the gathered information [88]. Although there are examples of utilization of penicillin allergy tests in outpatient settings, this service cannot be fully implemented in a community pharmacy due to related risks (i.e., probability of anaphylaxis) [89]. However, community pharmacists can conduct detailed interviews that can offer the basis for de-labelling and refer eligible patients to testing [90]. Removal of an unnecessary label is cost-effective and avoids bad treatment outcomes, treatment failures, surgical infections and multidrug-resistant infections [83].

2.4.2. Veterinary Drugs

Another field of interest concerns veterinary medicine, as community pharmacists are increasingly being involved in dispensing animals’ medications [91,92]. The extensive use of antibiotics in animal husbandry is considered an important contributor to microbial resistance, as antibiotics are not only used in treatment of developed infection but also as a growth promotor factor or prophylactic, often administered to an entire stock of animals [93,94]. Manure and other animal waste, as well as wastewater from farms, could be contaminated with antibiotics, their metabolites and resistant strains of bacteria [95,96,97]. Their improper disposal could also contaminate food sources, further propagating their resistance [96,98,99]. A survey found that roughly half of Italian veterinarians working on pig and cattle farms considered antimicrobial usage as not always in line with the guidelines [100]. In developing countries such as Ghana, more than 80% of farmers admitted they had bought antimicrobials over-the-counter without a prescription. The same study found that only 8.5% of antimicrobials were administered by veterinarians while the rest were administered by the farmers themselves, mostly based on their own experience rather than advice from healthcare workers [97]. In certain cases, the antibiotic was used in the form of an active pharmaceutical ingredient, instead of a finished drug product, and was usually added to animals’ feed [101]. Moreover, some antibiotics used were the ones meant for human use and considered critical for human health [102,103].
Antibiotic misuse in pet animals also presents risks due to longer contact with their owners, which could enable the transmission of resistant strains of bacteria to humans [93]. The World Organization for Animal Health recognized the potential contribution from the pharmacists in their guidelines for the responsible use of antibiotics in veterinary medicines. The guidelines propose the appropriate dispensing, labelling and record-keeping of the dispensed antimicrobials and other responsibilities of the pharmacists [104]. Despite their efforts, there were still cases where antimicrobial medications had been dispensed without valid prescription, which was especially prevalent in low- and middle-income countries, where the prescribing regulations were not adequately enforced [102,105]. In such countries, a pharmacist could have a more prominent role in antimicrobial stewardship. However, they seemed to be underutilized, as the farmers in those countries did not seek their advice about antibiotic choice, dosage or use [97,103]. Especially useful could be the pharmacists’ role as educators, as farmers are often aware of their overuse of antibiotics, or the existence of antimicrobial resistance, but still continue with their practice as they do not know its consequences on public health or alternative methods to prevent diseases [96,98,103,106]. Another concerning practice was discovered by a study in India where the veterinary antimicrobial medications for working animals were dispensed intentionally in wrong dosages and in higher quantities for financial gain [105]. Another obstacle in ensuring the proper use of antimicrobial drugs was the pharmacists’ perceived lack of knowledge about veterinary pharmacology, further potentiated by the lack of developed guidelines about antibiotics use in animals [91,92].

3. Conclusions

Community pharmacists recognize the need of implementing antimicrobial stewardship activities in community pharmacies. They are in a unique position to provide triage for common primary care indications and to lower the burden of patients to general practitioners’ offices. One of the basic elements should be antimicrobial dispensing according to regulations, either prescription-only, or according to guidelines where pharmacists have limited prescribing authority. This should be accompanied with patient consultation that may be facilitated using indication-specific education material (i.e., leaflets), which has proved to facilitate pharmacists–patient communication. Patients’ concerns should be addressed about possible adverse drug reactions, treatment duration, general practitioner referral and drug disposal. Patient education further may reduce patients’ expectations to receive antibiotics for self-limiting infections and reduce pressure on general practitioners to prescribe antibiotics on patients’ demand. Treatment optimization may be achieved through dose, duration of treatment and formulation optimization, either in collaboration with the prescribing general practitioners or by providing feedback. However, these are dependent on the general practitioners’ willingness to participate in such programs. At last, community pharmacists provided with additional training may be encouraged to provide consultation services to long-term care facilities, to introduce rapid antigen testing and point-of-care testing for infectious diseases and respiratory tract infections in their pharmacies, or prescribe antimicrobials for uncomplicated infections. These services are welcomed by patients and communities. Expanding pharmacy services and pharmacists’ prescribing autonomy have shown positive impacts by reducing antibiotics consumption, thus ensuring compliance with treatment guidelines.

Author Contributions

Conceptualization, D.R., D.M. and J.B. (Josko Bozic); methodology, D.R. and J.B. (Josko Bozic); literature search D.R., J.B. (Josipa Bukić), A.S.P., D.L., D.M., M.V. and A.P.; writing—original draft preparation, D.R., J.B. (Josipa Bukić) and D.L.; writing—review and editing, D.R., J.B. (Josipa Bukić), A.S.P., D.L., D.M., M.V. and J.B. (Josko Bozic); drafting the first version of the manuscript, D.R., D.L., J.B. (Josipa Bukić), M.V. and J.B. (Josko Bozic); visualization, D.R.; supervision, J.B. (Josko Bozic). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ferri, M.; Ranucci, E.; Romagnoli, P.; Giaccone, V. Antimicrobial resistance: A global emerging threat to public health systems. Crit. Rev. Food Sci. Nutr. 2017, 57, 2857–2876. [Google Scholar] [CrossRef] [PubMed]
  2. Hughes, D.; Andersson, D.I. Evolutionary Trajectories to Antibiotic Resistance. Annu. Rev. Microbiol. 2017, 71, 579–596. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Dyar, O.J.; Huttner, B.; Schouten, J.; Pulcini, C. What is antimicrobial stewardship? Clin. Microbiol. Infect. 2017, 23, 793–798. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Blanchette, L.; Gauthier, T.; Heil, E.; Klepser, M.; Kelly, K.M.; Nailor, M.; Wei, W.; Suda, K. Outpatient Stewardship Working, G. The essential role of pharmacists in antibiotic stewardship in outpatient care: An official position statement of the Society of Infectious Diseases Pharmacists. J. Am. Pharm. Assoc. 2018, 58, 481–484. [Google Scholar] [CrossRef]
  5. Anderson, D.J.; Watson, S.; Moehring, R.W.; Komarow, L.; Finnemeyer, M.; Arias, R.M.; Huvane, J.; Bova Hill, C.; Deckard, N.; Sexton, D.J.; et al. Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals. JAMA Netw. Open 2019, 2, e199369. [Google Scholar] [CrossRef]
  6. Resman, F. Antimicrobial stewardship programs; a two-part narrative review of step-wise design and issues of controversy Part I: Step-wise design of an antimicrobial stewardship program. Ther. Adv. Infect. Dis. 2020, 7, 2049936120933187. [Google Scholar] [CrossRef]
  7. Hall, J.W.; Bouchard, J.; Bookstaver, P.B.; Haldeman, M.S.; Kishimbo, P.; Mbwanji, G.; Mwakyula, I.; Mwasomola, D.; Seddon, M.; Shaffer, M.; et al. The Mbeya Antimicrobial Stewardship Team: Implementing Antimicrobial Stewardship at a Zonal-Level Hospital in Southern Tanzania. Pharmacy 2020, 8, 107. [Google Scholar] [CrossRef]
  8. Horumpende, P.G.; Sonda, T.B.; van Zwetselaar, M.; Antony, M.L.; Tenu, F.F.; Mwanziva, C.E.; Shao, E.R.; Mshana, S.E.; Mmbaga, B.T.; Chilongola, J.O. Prescription and non-prescription antibiotic dispensing practices in part I and part II pharmacies in Moshi Municipality, Kilimanjaro Region in Tanzania: A simulated clients approach. PLoS ONE 2018, 13, e0207465. [Google Scholar] [CrossRef] [Green Version]
  9. Koji, E.M.; Gebretekle, G.B.; Tekle, T.A. Practice of over-the-counter dispensary of antibiotics for childhood illnesses in Addis Ababa, Ethiopia: A simulated patient encounter study. Antimicrob. Resist. Infect. Control 2019, 8, 119. [Google Scholar] [CrossRef]
  10. Zawahir, S.; Lekamwasam, S.; Aslani, P. Community pharmacy staff’s response to symptoms of common infections: A pseudo-patient study. Antimicrob. Resist. Infect. Control 2019, 8, 60. [Google Scholar] [CrossRef] [Green Version]
  11. Hoxha, I.; Malaj, A.; Kraja, B.; Bino, S.; Oluka, M.; Markovic-Pekovic, V.; Godman, B. Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries. J. Glob. Antimicrob. Resist. 2018, 13, 240–245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Peiffer-Smadja, N.; Poda, A.; Ouedraogo, A.S.; Guiard-Schmid, J.B.; Delory, T.; Le Bel, J.; Bouvet, E.; Lariven, S.; Jeanmougin, P.; Ahmad, R.; et al. Paving the Way for the Implementation of a Decision Support System for Antibiotic Prescribing in Primary Care in West Africa: Preimplementation and Co-Design Workshop With Physicians. J. Med. Internet Res. 2020, 22, e17940. [Google Scholar] [CrossRef] [PubMed]
  13. Markovic-Pekovic, V.; Grubisa, N. Self-medication with antibiotics in the Republic of Srpska community pharmacies: Pharmacy staff behavior. Pharmacoepidemiol. Drug Saf. 2012, 21, 1130–1133. [Google Scholar] [CrossRef] [PubMed]
  14. Sabry, N.A.; Farid, S.F.; Dawoud, D.M. Antibiotic dispensing in Egyptian community pharmacies: An observational study. Res. Soc. Adm. Pharm. 2014, 10, 168–184. [Google Scholar] [CrossRef] [PubMed]
  15. Darj, E.; Newaz, M.S.; Zaman, M.H. Pharmacists’ perception of their challenges at work, focusing on antimicrobial resistance: A qualitative study from Bangladesh. Glob. Health Action 2019, 12, 1735126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Alhomoud, F.; Almahasnah, R.; Alhomoud, F.K. “You could lose when you misuse”—Factors affecting over-the-counter sale of antibiotics in community pharmacies in Saudi Arabia: A qualitative study. BMC Health Serv. Res. 2018, 18, 915. [Google Scholar] [CrossRef]
  17. Zakaa El-Din, M.; Samy, F.; Mohamed, A.; Hamdy, F.; Yasser, S.; Ehab, M. Egyptian community pharmacists’ attitudes and practices towards antibiotic dispensing and antibiotic resistance; a cross-sectional survey in Greater Cairo. Curr. Med. Res. Opin. 2019, 35, 939–946. [Google Scholar] [CrossRef]
  18. Auta, A.; Hadi, M.A.; Oga, E.; Adewuyi, E.O.; Abdu-Aguye, S.N.; Adeloye, D.; Strickland-Hodge, B.; Morgan, D.J. Global access to antibiotics without prescription in community pharmacies: A systematic review and meta-analysis. J. Infect. 2019, 78, 8–18. [Google Scholar] [CrossRef]
  19. Jamshed, S.; Padzil, F.; Shamsudin, S.H.; Bux, S.H.; Jamaluddin, A.A.; Bhagavathula, A.S.; Azhar, S.; Hassali, M.A. Antibiotic Stewardship in Community Pharmacies: A Scoping Review. Pharmacy 2018, 6, 92. [Google Scholar] [CrossRef] [Green Version]
  20. Feng, Z.; Hayat, K.; Huang, Z.; Shi, L.; Li, P.; Xiang, C.; Gong, Y.; Chang, J.; Jiang, M.; Yang, C.; et al. Knowledge, attitude, and practices of community pharmacy staff toward antimicrobial stewardship programs: A cross-sectional study from Northeastern China. Expert Rev. Anti Infect. Ther. 2020, 1–8. [Google Scholar] [CrossRef]
  21. Tonna, A.P.; Weidmann, A.E.; Sneddon, J.; Stewart, D. Views and experiences of community pharmacy team members on antimicrobial stewardship activities in Scotland: A qualitative study. Int. J. Clin. Pharm. 2020, 42, 1261–1269. [Google Scholar] [CrossRef] [PubMed]
  22. Rizvi, T.; Thompson, A.; Williams, M.; Zaidi, S.T.R. Validation and implementation of a national survey to assess antimicrobial stewardship awareness, practices and perceptions amongst community pharmacists in Australia. J. Glob. Antimicrob. Resist. 2020, 21, 28–33. [Google Scholar] [CrossRef] [PubMed]
  23. Sarwar, M.R.; Saqib, A.; Iftikhar, S.; Sadiq, T. Knowledge of community pharmacists about antibiotics, and their perceptions and practices regarding antimicrobial stewardship: A cross-sectional study in Punjab, Pakistan. Infect. Drug Resist. 2018, 11, 133–145. [Google Scholar] [CrossRef] [Green Version]
  24. Hayat, K.; Li, P.; Rosenthal, M.; Xu, S.; Chang, J.; Gillani, A.H.; Khan, F.U.; Sarwar, M.R.; Ji, S.; Shi, L.; et al. Perspective of community pharmacists about community-based antimicrobial stewardship programs. A multicenter cross-sectional study from China. Expert Rev. Anti Infect. Ther. 2019, 17, 1043–1050. [Google Scholar] [CrossRef] [PubMed]
  25. Ashiru-Oredope, D.; Doble, A.; Thornley, T.; Saei, A.; Gold, N.; Sallis, A.; McNulty, C.A.M.; Lecky, D.; Umoh, E.; Klinger, C. Improving Management of Respiratory Tract Infections in Community Pharmacies and Promoting Antimicrobial Stewardship: A Cluster Randomised Control Trial with a Self-Report Behavioural Questionnaire and Process Evaluation. Pharmacy 2020, 8, 44. [Google Scholar] [CrossRef] [Green Version]
  26. Khan, M.U.; Hassali, M.A.; Ahmad, A.; Elkalmi, R.M.; Zaidi, S.T.; Dhingra, S. Perceptions and Practices of Community Pharmacists towards Antimicrobial Stewardship in the State of Selangor, Malaysia. PLoS ONE 2016, 11, e0149623. [Google Scholar] [CrossRef]
  27. Rizvi, T.; Thompson, A.; Williams, M.; Zaidi, S.T.R. Perceptions and current practices of community pharmacists regarding antimicrobial stewardship in Tasmania. Int. J. Clin. Pharm. 2018, 40, 1380–1387. [Google Scholar] [CrossRef] [Green Version]
  28. Del Fiol Fde, S.; Barberato-Filho, S.; Lopes, L.C.; Bergamaschi Cda, C.; Boscariol, R. Assessment of Brazilian pharmacists’ knowledge about antimicrobial resistance. J. Infect. Dev. Ctries 2015, 9, 239–243. [Google Scholar] [CrossRef] [Green Version]
  29. Jones, L.F.; Owens, R.; Sallis, A.; Ashiru-Oredope, D.; Thornley, T.; Francis, N.A.; Butler, C.; McNulty, C.A.M. Qualitative study using interviews and focus groups to explore the current and potential for antimicrobial stewardship in community pharmacy informed by the Theoretical Domains Framework. BMJ Open 2018, 8, e025101. [Google Scholar] [CrossRef] [Green Version]
  30. Rehman, I.U.; Asad, M.M.; Bukhsh, A.; Ali, Z.; Ata, H.; Dujaili, J.A.; Blebil, A.Q.; Khan, T.M. Knowledge and Practice of Pharmacists toward Antimicrobial Stewardship in Pakistan. Pharmacy 2018, 6, 116. [Google Scholar] [CrossRef] [Green Version]
  31. Waseem, H.; Ali, J.; Sarwar, F.; Khan, A.; Rehman, H.S.U.; Choudri, M.; Arif, N.; Subhan, M.; Saleem, A.R.; Jamal, A.; et al. Assessment of knowledge and attitude trends towards antimicrobial resistance (AMR) among the community members, pharmacists/pharmacy owners and physicians in district Sialkot, Pakistan. Antimicrob. Resist. Infect. Control 2019, 8, 67. [Google Scholar] [CrossRef] [PubMed]
  32. Atif, M.; Asghar, S.; Mushtaq, I.; Malik, I. Community pharmacists as antibiotic stewards: A qualitative study exploring the current status of Antibiotic Stewardship Program in Bahawalpur, Pakistan. J. Infect. Public Health 2020, 13, 118–124. [Google Scholar] [CrossRef] [PubMed]
  33. Saleem, Z.; Hassali, M.A.; Hashmi, F.K.; Godman, B.; Saleem, F. Antimicrobial dispensing practices and determinants of antimicrobial resistance: A qualitative study among community pharmacists in Pakistan. Fam. Med. Community Health 2019, 7, e000138. [Google Scholar] [CrossRef] [PubMed]
  34. Atkins, L.; Chadborn, T.; Bondaronek, P.; Ashiru-Oredope, D.; Beech, E.; Herd, N.; de La Moriniere, V.; Gonzalez-Iraizoz, M.; Hopkins, S.; McNulty, C.; et al. Content and Mechanism of Action of National Antimicrobial Stewardship Interventions on Management of Respiratory Tract Infections in Primary and Community Care. Antibiotics 2020, 9, 512. [Google Scholar] [CrossRef]
  35. Revolinski, S.; Pawlak, J.; Beckers, C. Assessing Pharmacy Students’ and Preceptors’ Understanding of and Exposure to Antimicrobial Stewardship Practices on Introductory Pharmacy Practice Experiences. Pharmacy 2020, 8, 149. [Google Scholar] [CrossRef]
  36. Peiffer-Smadja, N.; Allison, R.; Jones, L.F.; Holmes, A.; Patel, P.; Lecky, D.M.; Ahmad, R.; McNulty, C.A.M. Preventing and Managing Urinary Tract Infections: Enhancing the Role of Community Pharmacists-A Mixed Methods Study. Antibiotics 2020, 9, 583. [Google Scholar] [CrossRef]
  37. Charani, E.; Castro-Sanchez, E.; Bradley, S.; Nathwani, D.; Holmes, A.H.; Davey, P. Implementation of antibiotic stewardship in different settings—Results of an international survey. Antimicrob. Resist. Infect. Control 2019, 8, 34. [Google Scholar] [CrossRef]
  38. Rusic, D.; Bozic, J.; Bukic, J.; Vilovic, M.; Tomicic, M.; Seselja Perisin, A.; Leskur, D.; Modun, D.; Cohadzic, T.; Tomic, S. Antimicrobial Resistance: Physicians’ and Pharmacists’ Perspective. Microb. Drug Resist. 2020. [Google Scholar] [CrossRef]
  39. Rusic, D.; Bozic, J.; Bukic, J.; Seselja Perisin, A.; Leskur, D.; Modun, D.; Tomic, S. Evaluation of accordance of antibiotics package size with recommended treatment duration of guidelines for sore throat and urinary tract infections. Antimicrob. Resist. Infect. Control 2019, 8, 30. [Google Scholar] [CrossRef]
  40. Jukic, I.; Rusic, D.; Vukovic, J.; Zivkovic, P.M.; Bukic, J.; Leskur, D.; Seselja Perisin, A.; Luksic, M.; Modun, D. Correlation of registered drug packs with Maastricht V/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection. Basic Clin. Pharmacol. Toxicol. 2020, 126, 212–225. [Google Scholar] [CrossRef]
  41. Jukic, I.; Rusic, D.; Vukovic, J.; Modun, D. Response to the Letter to the Editor entitled “Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment Consensuses: A poor or a proper match?”. Basic Clin. Pharmacol. Toxicol. 2020, 127, 8–9. [Google Scholar] [CrossRef] [PubMed]
  42. Dobson, E.L.; Klepser, M.E.; Pogue, J.M.; Labreche, M.J.; Adams, A.J.; Gauthier, T.P.; Turner, R.B.; Su, C.P.; Jacobs, D.M.; Suda, K.J.; et al. Outpatient antibiotic stewardship: Interventions and opportunities. J. Am. Pharm. Assoc. 2017, 57, 464–473. [Google Scholar] [CrossRef] [PubMed]
  43. Bishop, C.; Yacoob, Z.; Knobloch, M.J.; Safdar, N. Community pharmacy interventions to improve antibiotic stewardship and implications for pharmacy education: A narrative overview. Res. Soc. Adm. Pharm. 2019, 15, 627–631. [Google Scholar] [CrossRef] [PubMed]
  44. Parente, D.M.; Morton, J. Role of the Pharmacist in Antimicrobial Stewardship. Med. Clin. N. Am. 2018, 102, 929–936. [Google Scholar] [CrossRef] [PubMed]
  45. Hersh, A.L.; Fleming-Dutra, K.E.; Shapiro, D.J.; Hyun, D.Y.; Hicks, L.A.; Outpatient Antibiotic Use Target-Setting Workgroup. Frequency of First-line Antibiotic Selection Among US Ambulatory Care Visits for Otitis Media, Sinusitis, and Pharyngitis. JAMA Intern. Med. 2016, 176, 1870–1872. [Google Scholar] [CrossRef] [PubMed]
  46. O’Connor, R.; O’Doherty, J.; O’Regan, A.; Dunne, C. Antibiotic use for acute respiratory tract infections (ARTI) in primary care; what factors affect prescribing and why is it important? A narrative review. Ir. J. Med. Sci. 2018, 187, 969–986. [Google Scholar] [CrossRef] [Green Version]
  47. Klepser, M.E.; Dobson, E.L.; Pogue, J.M.; Labreche, M.J.; Adams, A.J.; Gauthier, T.P.; Turner, R.B.; Su, C.P.; Jacobs, D.M.; Suda, K.J.; et al. A call to action for outpatient antibiotic stewardship. J. Am. Pharm. Assoc. 2017, 57, 457–463. [Google Scholar] [CrossRef]
  48. Essack, S.; Bell, J.; Shephard, A. Community pharmacists-Leaders for antibiotic stewardship in respiratory tract infection. J. Clin. Pharm. Ther. 2018, 43, 302–307. [Google Scholar] [CrossRef] [Green Version]
  49. Wessels, M.R. Clinical practice. Streptococcal pharyngitis. N. Engl. J. Med. 2011, 364, 648–655. [Google Scholar] [CrossRef]
  50. Palla, A.H.; Khan, R.A.; Gilani, A.H.; Marra, F. Over prescription of antibiotics for adult pharyngitis is prevalent in developing countries but can be reduced using McIsaac modification of Centor scores: A cross-sectional study. BMC Pulm. Med. 2012, 12, 70. [Google Scholar] [CrossRef] [Green Version]
  51. Saengcharoen, W.; Jaisawang, P.; Udomcharoensab, P.; Buathong, K.; Lerkiatbundit, S. Appropriateness of diagnosis of streptococcal pharyngitis among Thai community pharmacists according to the Centor criteria. Int. J. Clin. Pharm. 2016, 38, 1318–1325. [Google Scholar] [CrossRef] [PubMed]
  52. Demore, B.; Tebano, G.; Gravoulet, J.; Wilcke, C.; Ruspini, E.; Birge, J.; Boivin, J.M.; Henard, S.; Dieterling, A.; Munerol, L.; et al. Rapid antigen test use for the management of group A streptococcal pharyngitis in community pharmacies. Eur. J. Clin. Microbiol. Infect. Dis. 2018, 37, 1637–1645. [Google Scholar] [CrossRef] [PubMed]
  53. Essack, S.; Bell, J.; Burgoyne, D.; Tongrod, W.; Duerden, M.; Sessa, A.; Altiner, A.; Shephard, A. Point-of-Care Testing for Pharyngitis in the Pharmacy. Antibiotics 2020, 9, 743. [Google Scholar] [CrossRef] [PubMed]
  54. Fraser, H.; Gallacher, D.; Achana, F.; Court, R.; Taylor-Phillips, S.; Nduka, C.; Stinton, C.; Willans, R.; Gill, P.; Mistry, H. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: Systematic reviews and economic evaluation. Health Technol. Assess. 2020, 24, 1–232. [Google Scholar] [CrossRef]
  55. Mantzourani, E.; Evans, A.; Cannings-John, R.; Ahmed, H.; Hood, K.; Reid, N.; Howe, R.; Williams, E.; Way, C. Impact of a pilot NHS-funded sore throat test and treat service in community pharmacies on provision and quality of patient care. BMJ Open Qual. 2020, 9, e000833. [Google Scholar] [CrossRef]
  56. Klepser, D.G.; Klepser, M.E.; Dering-Anderson, A.M.; Morse, J.A.; Smith, J.K.; Klepser, S.A. Community pharmacist-physician collaborative streptococcal pharyngitis management program. J. Am. Pharm. Assoc. 2016, 56, 323–329. [Google Scholar] [CrossRef]
  57. Thornley, T.; Marshall, G.; Howard, P.; Wilson, A.P. A feasibility service evaluation of screening and treatment of group A streptococcal pharyngitis in community pharmacies. J. Antimicrob. Chemother. 2016, 71, 3293–3299. [Google Scholar] [CrossRef] [Green Version]
  58. Klepser, D.G.; Klepser, M.E.; Murry, J.S.; Borden, H.; Olsen, K.M. Evaluation of a community pharmacy-based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing. J. Am. Pharm. Assoc. 2019, 59, 872–879. [Google Scholar] [CrossRef]
  59. Hawker, J.I.; Smith, S.; Smith, G.E.; Morbey, R.; Johnson, A.P.; Fleming, D.M.; Shallcross, L.; Hayward, A.C. Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: Analysis of a large database of primary care consultations. J. Antimicrob. Chemother. 2014, 69, 3423–3430. [Google Scholar] [CrossRef] [Green Version]
  60. Schroeck, J.L.; Ruh, C.A.; Sellick, J.A., Jr.; Ott, M.C.; Mattappallil, A.; Mergenhagen, K.A. Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. Antimicrob. Agents Chemother. 2015, 59, 3848–3852. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Albasri, A.; Van den Bruel, A.; Hayward, G.; McManus, R.J.; Sheppard, J.P.; Verbakel, J.Y.J. Impact of point-of-care tests in community pharmacies: A systematic review and meta-analysis. BMJ Open 2020, 10, e034298. [Google Scholar] [CrossRef] [PubMed]
  62. Pulcini, C.; Pauvif, L.; Paraponaris, A.; Verger, P.; Ventelou, B. Perceptions and attitudes of French general practitioners towards rapid antigen diagnostic tests in acute pharyngitis using a randomized case vignette study. J. Antimicrob. Chemother. 2012, 67, 1540–1546. [Google Scholar] [CrossRef] [PubMed]
  63. Klepser, M.E.; Adams, A.J. Pharmacy-based management of influenza: Lessons learned from research. Int. J. Pharm. Pract. 2018, 26, 573–578. [Google Scholar] [CrossRef] [PubMed]
  64. Corn, C.E.; Klepser, D.G.; Dering-Anderson, A.M.; Brown, T.G.; Klepser, M.E.; Smith, J.K. Observation of a Pharmacist-Conducted Group A Streptococcal Pharyngitis Point-of-Care Test: A Time and Motion Study. J. Pharm. Pract. 2018, 31, 284–291. [Google Scholar] [CrossRef] [PubMed]
  65. Mantzourani, E.; Hicks, R.; Evans, A.; Williams, E.; Way, C.; Deslandes, R. Community Pharmacist Views On The Early Stages Of Implementation Of A Pathfinder Sore Throat Test And Treat Service In Wales: An Exploratory Study. Integr. Pharm. Res. Pract. 2019, 8, 105–113. [Google Scholar] [CrossRef] [Green Version]
  66. Van der Velden, A.W.; Bell, J.; Sessa, A.; Duerden, M.; Altiner, A. Sore throat: Effective communication delivers improved diagnosis, enhanced self-care and more rational use of antibiotics. Int. J. Clin. Pract. Suppl. 2013, 67, 10–16. [Google Scholar] [CrossRef]
  67. Avent, M.L.; Fejzic, J.; van Driel, M.L. An underutilised resource for Antimicrobial Stewardship: A ‘snapshot’ of the community pharmacists’ role in delayed or ‘wait and see’ antibiotic prescribing. Int. J. Pharm. Pract. 2018, 26, 373–375. [Google Scholar] [CrossRef]
  68. Smieszek, T.; Pouwels, K.B.; Dolk, F.C.K.; Smith, D.R.M.; Hopkins, S.; Sharland, M.; Hay, A.D.; Moore, M.V.; Robotham, J.V. Potential for reducing inappropriate antibiotic prescribing in English primary care. J. Antimicrob. Chemother. 2018, 73, ii36–ii43. [Google Scholar] [CrossRef] [Green Version]
  69. McCormick, J.Z.; Cardwell, S.M.; Wheelock, C.; Wong, C.M.; Vander Weide, L.A. Impact of ambulatory antimicrobial stewardship on prescribing patterns for urinary tract infections. J. Clin. Pharm. Ther. 2020, 45, 1312–1319. [Google Scholar] [CrossRef]
  70. Gauld, N.J.; Zeng, I.S.; Ikram, R.B.; Thomas, M.G.; Buetow, S.A. Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim. Int. J. Clin. Pharm. 2017, 39, 165–172. [Google Scholar] [CrossRef]
  71. Beahm, N.P.; Smyth, D.J.; Tsuyuki, R.T. Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community. Can. Pharm. J. 2018, 151, 305–314. [Google Scholar] [CrossRef] [PubMed]
  72. Ung, E.; Czarniak, P.; Sunderland, B.; Parsons, R.; Hoti, K. Assessing pharmacists’ readiness to prescribe oral antibiotics for limited infections using a case-vignette technique. Int. J. Clin. Pharm. 2017, 39, 61–69. [Google Scholar] [CrossRef] [PubMed]
  73. Stewart, F.; Caldwell, G.; Cassells, K.; Burton, J.; Watson, A. Building capacity in primary care: The implementation of a novel ‘Pharmacy First’ scheme for the management of UTI, impetigo and COPD exacerbation. Prim. Health Care Res. Dev. 2018, 19, 531–541. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Sanyal, C.; Husereau, D.R.; Beahm, N.P.; Smyth, D.; Tsuyuki, R.T. Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists. BMC Health Serv. Res. 2019, 19, 499. [Google Scholar] [CrossRef] [Green Version]
  75. Booth, J.L.; Mullen, A.B.; Thomson, D.A.; Johnstone, C.; Galbraith, S.J.; Bryson, S.M.; McGovern, E.M. Antibiotic treatment of urinary tract infection by community pharmacists: A cross-sectional study. Br. J. Gen. Pract. 2013, 63, e244–e249. [Google Scholar] [CrossRef]
  76. Park, S.; Kang, J.E.; Choi, H.J.; Kim, C.J.; Chung, E.K.; Kim, S.A.; Rhie, S.J. Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis. Antibiotics 2019, 8, 252. [Google Scholar] [CrossRef] [Green Version]
  77. Waters, C.D. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. Am. J. Health Syst. Pharm. 2015, 72, 466–468. [Google Scholar] [CrossRef]
  78. Thornley, T.; Ashiru-Oredope, D.; Beech, E.; Howard, P.; Kirkdale, C.L.; Elliott, H.; Harris, C.; Roberts, A. Antimicrobial use in UK long-term care facilities: Results of a point prevalence survey. J. Antimicrob. Chemother. 2019, 74, 2083–2090. [Google Scholar] [CrossRef] [Green Version]
  79. Thornley, T.; Ashiru-Oredope, D.; Normington, A.; Beech, E.; Howard, P. Antibiotic prescribing for residents in long-term-care facilities across the UK. J. Antimicrob. Chemother. 2019, 74, 1447–1451. [Google Scholar] [CrossRef]
  80. Takito, S.; Kusama, Y.; Fukuda, H.; Kutsuna, S. Pharmacist-supported antimicrobial stewardship in a retirement home. J. Infect. Chemother. 2020, 26, 858–861. [Google Scholar] [CrossRef]
  81. Bush, K.; Bradford, P.A. beta-Lactams and beta-Lactamase Inhibitors: An Overview. Cold Spring Harb. Perspect. Med. 2016, 6, a025247. [Google Scholar] [CrossRef] [PubMed]
  82. Dolk, F.; Pouwels, K.B.; Smith, D.; Robotham, J.V.; Smieszek, T. Antibiotics in primary care in England: Which antibiotics are prescribed and for which conditions? J. Antimicrob. Chemother. 2018, 73, ii2–ii10. [Google Scholar] [CrossRef] [PubMed]
  83. Stone, C.A., Jr.; Trubiano, J.; Coleman, D.T.; Rukasin, C.R.F.; Phillips, E.J. The challenge of de-labeling penicillin allergy. Allergy 2020, 75, 273–288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Sacco, K.A.; Bates, A.; Brigham, T.J.; Imam, J.S.; Burton, M.C. Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis. Allergy 2017, 72, 1288–1296. [Google Scholar] [CrossRef] [PubMed]
  85. Devchand, M.; Kirkpatrick, C.M.J.; Stevenson, W.; Garrett, K.; Perera, D.; Khumra, S.; Urbancic, K.; Grayson, M.L.; Trubiano, J.A. Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: A novel antimicrobial stewardship intervention. J. Antimicrob. Chemother. 2019, 74, 1725–1730. [Google Scholar] [CrossRef]
  86. Cheon, E.; Horowitz, H.W. New Avenues for Antimicrobial Stewardship: The Case for Penicillin Skin Testing by Pharmacists. Clin. Infect. Dis. 2019, 68, 2123–2124. [Google Scholar] [CrossRef]
  87. Gugkaeva, Z.; Crago, J.S.; Yasnogorodsky, M. Next step in antibiotic stewardship: Pharmacist-provided penicillin allergy testing. J. Clin. Pharm. Ther. 2017, 42, 509–512. [Google Scholar] [CrossRef] [Green Version]
  88. Park, M.A.; McClimon, B.J.; Ferguson, B.; Markus, P.J.; Odell, L.; Swanson, A.; Kloos-Olson, K.E.; Bjerke, P.F.; Li, J.T. Collaboration between allergists and pharmacists increases beta-lactam antibiotic prescriptions in patients with a history of penicillin allergy. Int. Arch. Allergy Immunol. 2011, 154, 57–62. [Google Scholar] [CrossRef]
  89. Macy, E.; Shu, Y.H. The Effect of Penicillin Allergy Testing on Future Health Care Utilization: A Matched Cohort Study. J. Allergy Clin. Immunol. Pract. 2017, 5, 705–710. [Google Scholar] [CrossRef]
  90. Blumenthal, K.G.; Li, Y.; Banerji, A.; Yun, B.J.; Long, A.A.; Walensky, R.P. The Cost of Penicillin Allergy Evaluation. J. Allergy Clin. Immunol. Pract. 2018, 6, 1019–1027. [Google Scholar] [CrossRef]
  91. McDowell, A.; Beard, R.; Brightmore, A.; Lu, L.W.; McKay, A.; Mistry, M.; Owen, K.; Swan, E.; Young, J. Veterinary Pharmaceutics: An Opportunity for Interprofessional Education in New Zealand? Pharmaceutics 2017, 9, 25. [Google Scholar] [CrossRef] [Green Version]
  92. Fredrickson, M.E.; Terlizzi, H.; Horne, R.L.; Dannemiller, S. The role of the community pharmacist in veterinary patient care: A cross-sectional study of pharmacist and veterinarian viewpoints. Pharm. Pract. 2020, 18, 1928. [Google Scholar] [CrossRef] [PubMed]
  93. Palma, E.; Tilocca, B.; Roncada, P. Antimicrobial Resistance in Veterinary Medicine: An Overview. Int. J. Mol. Sci. 2020, 21, 1914. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Omwenga, I.; Aboge, G.O.; Mitema, E.S.; Obiero, G.; Ngaywa, C.; Ngwili, N.; Wamwere, G.; Wainaina, M.; Bett, B. Antimicrobial Usage and Detection of Multidrug-Resistant Staphylococcus aureus, Including Methicillin-Resistant Strains in Raw Milk of Livestock from Northern Kenya. Microb. Drug Resist. 2020. [Google Scholar] [CrossRef] [PubMed]
  95. Lunha, K.; Leangapichart, T.; Jiwakanon, J.; Angkititrakul, S.; Sunde, M.; Jarhult, J.D.; Strom Hallenberg, G.; Hickman, R.A.; Van Boeckel, T.; Magnusson, U. Antimicrobial Resistance in Fecal Escherichia coli from Humans and Pigs at Farms at Different Levels of Intensification. Antibiotics 2020, 9, 662. [Google Scholar] [CrossRef]
  96. Andrew Selaledi, L.; Mohammed Hassan, Z.; Manyelo, T.G.; Mabelebele, M. The Current Status of the Alternative Use to Antibiotics in Poultry Production: An African Perspective. Antibiotics 2020, 9, 594. [Google Scholar] [CrossRef]
  97. Phares, C.A.; Danquah, A.; Atiah, K.; Agyei, F.K.; Michael, O.T. Antibiotics utilization and farmers’ knowledge of its effects on soil ecosystem in the coastal drylands of Ghana. PLoS ONE 2020, 15, e0228777. [Google Scholar] [CrossRef] [Green Version]
  98. Al-Mustapha, A.I.; Adetunji, V.O.; Heikinheimo, A. Risk Perceptions of Antibiotic Usage and Resistance: A Cross-Sectional Survey of Poultry Farmers in Kwara State, Nigeria. Antibiotics 2020, 9, 378. [Google Scholar] [CrossRef]
  99. Bergspica, I.; Kaprou, G.; Alexa, E.A.; Prieto, M.; Alvarez-Ordonez, A. Extended Spectrum beta-Lactamase (ESBL) Producing Escherichia coli in Pigs and Pork Meat in the European Union. Antibiotics 2020, 9, 678. [Google Scholar] [CrossRef]
  100. Pozza, G.; Pinto, A.; Crovato, S.; Mascarello, G.; Bano, L.; Dacasto, M.; Battisti, A.; Bartoli, B.; Ravarotto, L.; Marangon, S. Antimicrobial use and antimicrobial resistance: Standpoint and prescribing behaviour of Italian cattle and pig veterinarians. Ital. J. Anim. Sci. 2020, 19, 905–916. [Google Scholar] [CrossRef]
  101. Sommanustweechai, A.; Chanvatik, S.; Sermsinsiri, V.; Sivilaikul, S.; Patcharanarumol, W.; Yeung, S.; Tangcharoensathien, V. Antibiotic distribution channels in Thailand: Results of key-informant interviews, reviews of drug regulations and database searches. Bull. World Health Organ. 2018, 96, 101–109. [Google Scholar] [CrossRef] [PubMed]
  102. Wilkinson, A.; Ebata, A.; MacGregor, H. Interventions to Reduce Antibiotic Prescribing in LMICs: A Scoping Review of Evidence from Human and Animal Health Systems. Antibiotics 2018, 8, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Afakye, K.; Kiambi, S.; Koka, E.; Kabali, E.; Dorado-Garcia, A.; Amoah, A.; Kimani, T.; Adjei, B.; Caudell, M.A. The Impacts of Animal Health Service Providers on Antimicrobial Use Attitudes and Practices: An Examination of Poultry Layer Farmers in Ghana and Kenya. Antibiotics 2020, 9, 554. [Google Scholar] [CrossRef] [PubMed]
  104. Anthony, F.; Acar, J.; Franklin, A.; Gupta, R.; Nicholls, T.; Tamura, Y.; Thompson, S.; Threlfall, E.J.; Vose, D.; van Vuuren, M.; et al. Antimicrobial resistance: Responsible and prudent use of antimicrobial agents in veterinary medicine. Rev. Sci. Tech. 2001, 20, 829–839. [Google Scholar] [CrossRef] [PubMed]
  105. Nye, C.; Watson, T.; Kubasiewicz, L.; Raw, Z.; Burden, F. No Prescription, No Problem! A Mixed-Methods Study of Antimicrobial Stewardship Relating to Working Equines in Drug Retail Outlets of Northern India. Antibiotics 2020, 9, 295. [Google Scholar] [CrossRef]
  106. Martino, G.; Crovato, S.; Pinto, A.; Dorotea, T.; Mascarello, G.; Brunetta, R.; Fabrizio Agnoletti, F.; Bonfanti, L. Farmers’ attitudes towards antimicrobial use and awareness of antimicrobial resistance: A comparative study among turkey and rabbit farmers. Ital. J. Anim. Sci. 2019, 18, 194–201. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Antimicrobial stewardship opportunities in community pharmacies.
Figure 1. Antimicrobial stewardship opportunities in community pharmacies.
Antibiotics 10 00063 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rusic, D.; Bukić, J.; Seselja Perisin, A.; Leskur, D.; Modun, D.; Petric, A.; Vilovic, M.; Bozic, J. Are We Making the Most of Community Pharmacies? Implementation of Antimicrobial Stewardship Measures in Community Pharmacies: A Narrative Review. Antibiotics 2021, 10, 63. https://doi.org/10.3390/antibiotics10010063

AMA Style

Rusic D, Bukić J, Seselja Perisin A, Leskur D, Modun D, Petric A, Vilovic M, Bozic J. Are We Making the Most of Community Pharmacies? Implementation of Antimicrobial Stewardship Measures in Community Pharmacies: A Narrative Review. Antibiotics. 2021; 10(1):63. https://doi.org/10.3390/antibiotics10010063

Chicago/Turabian Style

Rusic, Doris, Josipa Bukić, Ana Seselja Perisin, Dario Leskur, Darko Modun, Ana Petric, Marino Vilovic, and Josko Bozic. 2021. "Are We Making the Most of Community Pharmacies? Implementation of Antimicrobial Stewardship Measures in Community Pharmacies: A Narrative Review" Antibiotics 10, no. 1: 63. https://doi.org/10.3390/antibiotics10010063

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop